Pharma & Healthcare
Global Basal Insulin (Long-Acting Insulin) Market Research Report 2025
- Jul 28, 25
- ID: 409186
- Pages: 84
- Figures: 80
- Views: 6
The global market for Basal Insulin (Long-Acting Insulin) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Long-acting insulins are also called basal or background insulins. The role of basal insulin, also known as background insulin, is to keep blood glucose levels at consistent levels during periods of fasting. When fasting , the body steadily releases glucose into the blood to our cells supplied with energy.
North American market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Basal Insulin (Long-Acting Insulin) include Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico, Wockhardt, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Basal Insulin (Long-Acting Insulin), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Basal Insulin (Long-Acting Insulin).
The Basal Insulin (Long-Acting Insulin) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Basal Insulin (Long-Acting Insulin) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Basal Insulin (Long-Acting Insulin) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novo Nordisk
Sanofi Aventis
Eli Lilly
Biocon
Julphar
Exir
Sedico
Wockhardt
Segment by Type
Lantus
Levemir
Tresiba
Toujeo
Basaglar
Biosimilar Glargines
Segment by Application
Type 1 Diabetes
Type 2 Diabetes
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Basal Insulin (Long-Acting Insulin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Basal Insulin (Long-Acting Insulin) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Long-acting insulins are also called basal or background insulins. The role of basal insulin, also known as background insulin, is to keep blood glucose levels at consistent levels during periods of fasting. When fasting , the body steadily releases glucose into the blood to our cells supplied with energy.
North American market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Basal Insulin (Long-Acting Insulin) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Basal Insulin (Long-Acting Insulin) include Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico, Wockhardt, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Basal Insulin (Long-Acting Insulin), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Basal Insulin (Long-Acting Insulin).
The Basal Insulin (Long-Acting Insulin) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Basal Insulin (Long-Acting Insulin) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Basal Insulin (Long-Acting Insulin) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novo Nordisk
Sanofi Aventis
Eli Lilly
Biocon
Julphar
Exir
Sedico
Wockhardt
Segment by Type
Lantus
Levemir
Tresiba
Toujeo
Basaglar
Biosimilar Glargines
Segment by Application
Type 1 Diabetes
Type 2 Diabetes
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Basal Insulin (Long-Acting Insulin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Basal Insulin (Long-Acting Insulin) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Basal Insulin (Long-Acting Insulin) Market Overview
1.1 Product Definition
1.2 Basal Insulin (Long-Acting Insulin) by Type
1.2.1 Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lantus
1.2.3 Levemir
1.2.4 Tresiba
1.2.5 Toujeo
1.2.6 Basaglar
1.2.7 Biosimilar Glargines
1.3 Basal Insulin (Long-Acting Insulin) by Application
1.3.1 Global Basal Insulin (Long-Acting Insulin) Market Value by Application (2024 VS 2031)
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Basal Insulin (Long-Acting Insulin) Market Size Estimates and Forecasts
1.4.1 Global Basal Insulin (Long-Acting Insulin) Revenue 2020-2031
1.4.2 Global Basal Insulin (Long-Acting Insulin) Sales 2020-2031
1.4.3 Global Basal Insulin (Long-Acting Insulin) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Basal Insulin (Long-Acting Insulin) Market Competition by Manufacturers
2.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Basal Insulin (Long-Acting Insulin) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Basal Insulin (Long-Acting Insulin), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Product Type & Application
2.7 Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Date of Enter into This Industry
2.8 Global Basal Insulin (Long-Acting Insulin) Market Competitive Situation and Trends
2.8.1 Global Basal Insulin (Long-Acting Insulin) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Basal Insulin (Long-Acting Insulin) Players Market Share by Revenue
2.8.3 Global Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Basal Insulin (Long-Acting Insulin) Market Scenario by Region
3.1 Global Basal Insulin (Long-Acting Insulin) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2020-2031
3.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2020-2025
3.2.2 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2026-2031
3.3 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2020-2031
3.3.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2020-2025
3.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2026-2031
3.4 North America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.4.1 North America Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.4.3 North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.5.1 Europe Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.5.3 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Region
3.6.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2020-2031)
3.6.3 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.7.1 Latin America Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.7.3 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.8.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2020-2031)
4.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2020-2025)
4.1.2 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2026-2031)
4.1.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2020-2031)
4.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2020-2031)
4.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2020-2025)
4.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2026-2031)
4.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2020-2031)
4.3 Global Basal Insulin (Long-Acting Insulin) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2020-2031)
5.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2020-2025)
5.1.2 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2026-2031)
5.1.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2020-2031)
5.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2020-2031)
5.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2020-2025)
5.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2026-2031)
5.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2020-2031)
5.3 Global Basal Insulin (Long-Acting Insulin) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi Aventis
6.2.1 Sanofi Aventis Company Information
6.2.2 Sanofi Aventis Description and Business Overview
6.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolio
6.2.5 Sanofi Aventis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Biocon
6.4.1 Biocon Company Information
6.4.2 Biocon Description and Business Overview
6.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biocon Basal Insulin (Long-Acting Insulin) Product Portfolio
6.4.5 Biocon Recent Developments/Updates
6.5 Julphar
6.5.1 Julphar Company Information
6.5.2 Julphar Description and Business Overview
6.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Julphar Basal Insulin (Long-Acting Insulin) Product Portfolio
6.5.5 Julphar Recent Developments/Updates
6.6 Exir
6.6.1 Exir Company Information
6.6.2 Exir Description and Business Overview
6.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Exir Basal Insulin (Long-Acting Insulin) Product Portfolio
6.6.5 Exir Recent Developments/Updates
6.7 Sedico
6.7.1 Sedico Company Information
6.7.2 Sedico Description and Business Overview
6.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sedico Basal Insulin (Long-Acting Insulin) Product Portfolio
6.7.5 Sedico Recent Developments/Updates
6.8 Wockhardt
6.8.1 Wockhardt Company Information
6.8.2 Wockhardt Description and Business Overview
6.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolio
6.8.5 Wockhardt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Basal Insulin (Long-Acting Insulin) Industry Chain Analysis
7.2 Basal Insulin (Long-Acting Insulin) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Basal Insulin (Long-Acting Insulin) Production Mode & Process Analysis
7.4 Basal Insulin (Long-Acting Insulin) Sales and Marketing
7.4.1 Basal Insulin (Long-Acting Insulin) Sales Channels
7.4.2 Basal Insulin (Long-Acting Insulin) Distributors
7.5 Basal Insulin (Long-Acting Insulin) Customer Analysis
8 Basal Insulin (Long-Acting Insulin) Market Dynamics
8.1 Basal Insulin (Long-Acting Insulin) Industry Trends
8.2 Basal Insulin (Long-Acting Insulin) Market Drivers
8.3 Basal Insulin (Long-Acting Insulin) Market Challenges
8.4 Basal Insulin (Long-Acting Insulin) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Basal Insulin (Long-Acting Insulin) by Type
1.2.1 Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Lantus
1.2.3 Levemir
1.2.4 Tresiba
1.2.5 Toujeo
1.2.6 Basaglar
1.2.7 Biosimilar Glargines
1.3 Basal Insulin (Long-Acting Insulin) by Application
1.3.1 Global Basal Insulin (Long-Acting Insulin) Market Value by Application (2024 VS 2031)
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Basal Insulin (Long-Acting Insulin) Market Size Estimates and Forecasts
1.4.1 Global Basal Insulin (Long-Acting Insulin) Revenue 2020-2031
1.4.2 Global Basal Insulin (Long-Acting Insulin) Sales 2020-2031
1.4.3 Global Basal Insulin (Long-Acting Insulin) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Basal Insulin (Long-Acting Insulin) Market Competition by Manufacturers
2.1 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Basal Insulin (Long-Acting Insulin) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Basal Insulin (Long-Acting Insulin), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Product Type & Application
2.7 Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Date of Enter into This Industry
2.8 Global Basal Insulin (Long-Acting Insulin) Market Competitive Situation and Trends
2.8.1 Global Basal Insulin (Long-Acting Insulin) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Basal Insulin (Long-Acting Insulin) Players Market Share by Revenue
2.8.3 Global Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Basal Insulin (Long-Acting Insulin) Market Scenario by Region
3.1 Global Basal Insulin (Long-Acting Insulin) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2020-2031
3.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2020-2025
3.2.2 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2026-2031
3.3 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2020-2031
3.3.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2020-2025
3.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2026-2031
3.4 North America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.4.1 North America Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.4.3 North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.5.1 Europe Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.5.3 Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Region
3.6.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2020-2031)
3.6.3 Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.7.1 Latin America Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.7.3 Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Facts & Figures by Country
3.8.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2020-2031)
4.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2020-2025)
4.1.2 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2026-2031)
4.1.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2020-2031)
4.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2020-2031)
4.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2020-2025)
4.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2026-2031)
4.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2020-2031)
4.3 Global Basal Insulin (Long-Acting Insulin) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2020-2031)
5.1.1 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2020-2025)
5.1.2 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2026-2031)
5.1.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2020-2031)
5.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2020-2031)
5.2.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2020-2025)
5.2.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2026-2031)
5.2.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2020-2031)
5.3 Global Basal Insulin (Long-Acting Insulin) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi Aventis
6.2.1 Sanofi Aventis Company Information
6.2.2 Sanofi Aventis Description and Business Overview
6.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolio
6.2.5 Sanofi Aventis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Company Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Biocon
6.4.1 Biocon Company Information
6.4.2 Biocon Description and Business Overview
6.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biocon Basal Insulin (Long-Acting Insulin) Product Portfolio
6.4.5 Biocon Recent Developments/Updates
6.5 Julphar
6.5.1 Julphar Company Information
6.5.2 Julphar Description and Business Overview
6.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Julphar Basal Insulin (Long-Acting Insulin) Product Portfolio
6.5.5 Julphar Recent Developments/Updates
6.6 Exir
6.6.1 Exir Company Information
6.6.2 Exir Description and Business Overview
6.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Exir Basal Insulin (Long-Acting Insulin) Product Portfolio
6.6.5 Exir Recent Developments/Updates
6.7 Sedico
6.7.1 Sedico Company Information
6.7.2 Sedico Description and Business Overview
6.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sedico Basal Insulin (Long-Acting Insulin) Product Portfolio
6.7.5 Sedico Recent Developments/Updates
6.8 Wockhardt
6.8.1 Wockhardt Company Information
6.8.2 Wockhardt Description and Business Overview
6.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolio
6.8.5 Wockhardt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Basal Insulin (Long-Acting Insulin) Industry Chain Analysis
7.2 Basal Insulin (Long-Acting Insulin) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Basal Insulin (Long-Acting Insulin) Production Mode & Process Analysis
7.4 Basal Insulin (Long-Acting Insulin) Sales and Marketing
7.4.1 Basal Insulin (Long-Acting Insulin) Sales Channels
7.4.2 Basal Insulin (Long-Acting Insulin) Distributors
7.5 Basal Insulin (Long-Acting Insulin) Customer Analysis
8 Basal Insulin (Long-Acting Insulin) Market Dynamics
8.1 Basal Insulin (Long-Acting Insulin) Industry Trends
8.2 Basal Insulin (Long-Acting Insulin) Market Drivers
8.3 Basal Insulin (Long-Acting Insulin) Market Challenges
8.4 Basal Insulin (Long-Acting Insulin) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Basal Insulin (Long-Acting Insulin) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Basal Insulin (Long-Acting Insulin) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Basal Insulin (Long-Acting Insulin), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Product Type & Application
Table 12. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Basal Insulin (Long-Acting Insulin) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Basal Insulin (Long-Acting Insulin) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2020-2025) & (K Units)
Table 18. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2020-2025)
Table 19. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2026-2031) & (K Units)
Table 20. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2026-2031)
Table 21. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2020-2025)
Table 23. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2026-2031)
Table 25. North America Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
Table 27. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
Table 28. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
Table 32. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
Table 33. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2020-2025)
Table 51. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2026-2031)
Table 52. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2020-2025)
Table 53. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2026-2031)
Table 54. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2020-2025)
Table 57. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2026-2031)
Table 58. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2020-2025)
Table 59. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2026-2031)
Table 60. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2020-2025)
Table 61. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2026-2031)
Table 62. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2020-2025)
Table 63. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2026-2031)
Table 64. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2020-2025)
Table 67. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2026-2031)
Table 68. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2020-2025)
Table 69. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2026-2031)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Aventis Company Information
Table 76. Sanofi Aventis Description and Business Overview
Table 77. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product
Table 79. Sanofi Aventis Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Eli Lilly Basal Insulin (Long-Acting Insulin) Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Biocon Company Information
Table 86. Biocon Description and Business Overview
Table 87. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Biocon Basal Insulin (Long-Acting Insulin) Product
Table 89. Biocon Recent Developments/Updates
Table 90. Julphar Company Information
Table 91. Julphar Description and Business Overview
Table 92. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Julphar Basal Insulin (Long-Acting Insulin) Product
Table 94. Julphar Recent Developments/Updates
Table 95. Exir Company Information
Table 96. Exir Description and Business Overview
Table 97. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Exir Basal Insulin (Long-Acting Insulin) Product
Table 99. Exir Recent Developments/Updates
Table 100. Sedico Company Information
Table 101. Sedico Description and Business Overview
Table 102. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Sedico Basal Insulin (Long-Acting Insulin) Product
Table 104. Sedico Recent Developments/Updates
Table 105. Wockhardt Company Information
Table 106. Wockhardt Description and Business Overview
Table 107. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Wockhardt Basal Insulin (Long-Acting Insulin) Product
Table 109. Wockhardt Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Basal Insulin (Long-Acting Insulin) Distributors List
Table 113. Basal Insulin (Long-Acting Insulin) Customers List
Table 114. Basal Insulin (Long-Acting Insulin) Market Trends
Table 115. Basal Insulin (Long-Acting Insulin) Market Drivers
Table 116. Basal Insulin (Long-Acting Insulin) Market Challenges
Table 117. Basal Insulin (Long-Acting Insulin) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Basal Insulin (Long-Acting Insulin)
Figure 2. Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Basal Insulin (Long-Acting Insulin) Market Share by Type: 2024 & 2031
Figure 4. Lantus Product Picture
Figure 5. Levemir Product Picture
Figure 6. Tresiba Product Picture
Figure 7. Toujeo Product Picture
Figure 8. Basaglar Product Picture
Figure 9. Biosimilar Glargines Product Picture
Figure 10. Global Basal Insulin (Long-Acting Insulin) Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Basal Insulin (Long-Acting Insulin) Market Share by Application: 2024 & 2031
Figure 12. Type 1 Diabetes
Figure 13. Type 2 Diabetes
Figure 14. Global Basal Insulin (Long-Acting Insulin) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Basal Insulin (Long-Acting Insulin) Market Size (2020-2031) & (US$ Million)
Figure 16. Global Basal Insulin (Long-Acting Insulin) Sales (2020-2031) & (K Units)
Figure 17. Global Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) & (2020-2031)
Figure 18. Basal Insulin (Long-Acting Insulin) Report Years Considered
Figure 19. Basal Insulin (Long-Acting Insulin) Sales Share by Manufacturers in 2024
Figure 20. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Basal Insulin (Long-Acting Insulin) Players: Market Share by Revenue in Basal Insulin (Long-Acting Insulin) in 2024
Figure 22. Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Basal Insulin (Long-Acting Insulin) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
Figure 25. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
Figure 26. United States Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
Figure 29. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
Figure 30. Germany Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2020-2031)
Figure 37. China Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
Figure 47. Latin America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Basal Insulin (Long-Acting Insulin) by Type (2020-2031)
Figure 57. Global Revenue Market Share of Basal Insulin (Long-Acting Insulin) by Type (2020-2031)
Figure 58. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Basal Insulin (Long-Acting Insulin) by Application (2020-2031)
Figure 60. Global Revenue Market Share of Basal Insulin (Long-Acting Insulin) by Application (2020-2031)
Figure 61. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2020-2031)
Figure 62. Basal Insulin (Long-Acting Insulin) Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Basal Insulin (Long-Acting Insulin) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Basal Insulin (Long-Acting Insulin) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Basal Insulin (Long-Acting Insulin), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Product Type & Application
Table 12. Global Key Manufacturers of Basal Insulin (Long-Acting Insulin), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Basal Insulin (Long-Acting Insulin) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Basal Insulin (Long-Acting Insulin) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2020-2025) & (K Units)
Table 18. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2020-2025)
Table 19. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2026-2031) & (K Units)
Table 20. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2026-2031)
Table 21. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2020-2025)
Table 23. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2026-2031)
Table 25. North America Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
Table 27. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
Table 28. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
Table 32. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
Table 33. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2020-2025)
Table 51. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2026-2031)
Table 52. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2020-2025)
Table 53. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2026-2031)
Table 54. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2020-2025)
Table 57. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2026-2031)
Table 58. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2020-2025)
Table 59. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2026-2031)
Table 60. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2020-2025)
Table 61. Global Basal Insulin (Long-Acting Insulin) Sales (K Units) by Application (2026-2031)
Table 62. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2020-2025)
Table 63. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2026-2031)
Table 64. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Basal Insulin (Long-Acting Insulin) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2020-2025)
Table 67. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2026-2031)
Table 68. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2020-2025)
Table 69. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2026-2031)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. Sanofi Aventis Company Information
Table 76. Sanofi Aventis Description and Business Overview
Table 77. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product
Table 79. Sanofi Aventis Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Eli Lilly Basal Insulin (Long-Acting Insulin) Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Biocon Company Information
Table 86. Biocon Description and Business Overview
Table 87. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Biocon Basal Insulin (Long-Acting Insulin) Product
Table 89. Biocon Recent Developments/Updates
Table 90. Julphar Company Information
Table 91. Julphar Description and Business Overview
Table 92. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Julphar Basal Insulin (Long-Acting Insulin) Product
Table 94. Julphar Recent Developments/Updates
Table 95. Exir Company Information
Table 96. Exir Description and Business Overview
Table 97. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Exir Basal Insulin (Long-Acting Insulin) Product
Table 99. Exir Recent Developments/Updates
Table 100. Sedico Company Information
Table 101. Sedico Description and Business Overview
Table 102. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Sedico Basal Insulin (Long-Acting Insulin) Product
Table 104. Sedico Recent Developments/Updates
Table 105. Wockhardt Company Information
Table 106. Wockhardt Description and Business Overview
Table 107. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Wockhardt Basal Insulin (Long-Acting Insulin) Product
Table 109. Wockhardt Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Basal Insulin (Long-Acting Insulin) Distributors List
Table 113. Basal Insulin (Long-Acting Insulin) Customers List
Table 114. Basal Insulin (Long-Acting Insulin) Market Trends
Table 115. Basal Insulin (Long-Acting Insulin) Market Drivers
Table 116. Basal Insulin (Long-Acting Insulin) Market Challenges
Table 117. Basal Insulin (Long-Acting Insulin) Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Basal Insulin (Long-Acting Insulin)
Figure 2. Global Basal Insulin (Long-Acting Insulin) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Basal Insulin (Long-Acting Insulin) Market Share by Type: 2024 & 2031
Figure 4. Lantus Product Picture
Figure 5. Levemir Product Picture
Figure 6. Tresiba Product Picture
Figure 7. Toujeo Product Picture
Figure 8. Basaglar Product Picture
Figure 9. Biosimilar Glargines Product Picture
Figure 10. Global Basal Insulin (Long-Acting Insulin) Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Basal Insulin (Long-Acting Insulin) Market Share by Application: 2024 & 2031
Figure 12. Type 1 Diabetes
Figure 13. Type 2 Diabetes
Figure 14. Global Basal Insulin (Long-Acting Insulin) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Basal Insulin (Long-Acting Insulin) Market Size (2020-2031) & (US$ Million)
Figure 16. Global Basal Insulin (Long-Acting Insulin) Sales (2020-2031) & (K Units)
Figure 17. Global Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) & (2020-2031)
Figure 18. Basal Insulin (Long-Acting Insulin) Report Years Considered
Figure 19. Basal Insulin (Long-Acting Insulin) Sales Share by Manufacturers in 2024
Figure 20. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Basal Insulin (Long-Acting Insulin) Players: Market Share by Revenue in Basal Insulin (Long-Acting Insulin) in 2024
Figure 22. Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Basal Insulin (Long-Acting Insulin) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
Figure 25. North America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
Figure 26. United States Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
Figure 29. Europe Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
Figure 30. Germany Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2020-2031)
Figure 37. China Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
Figure 47. Latin America Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Basal Insulin (Long-Acting Insulin) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Basal Insulin (Long-Acting Insulin) by Type (2020-2031)
Figure 57. Global Revenue Market Share of Basal Insulin (Long-Acting Insulin) by Type (2020-2031)
Figure 58. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Basal Insulin (Long-Acting Insulin) by Application (2020-2031)
Figure 60. Global Revenue Market Share of Basal Insulin (Long-Acting Insulin) by Application (2020-2031)
Figure 61. Global Basal Insulin (Long-Acting Insulin) Price (US$/Unit) by Application (2020-2031)
Figure 62. Basal Insulin (Long-Acting Insulin) Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fatigue Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global Blast Impact Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global On-Line Analytical Processing (OLAP) Business Intelligence Consulting Services Market Research Report 2025
Jul 29, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232